Does perimenopause lead to low luteal progesterone due to more anovulatory cycles and impaired corpus luteum function?

During the perimenopausal transition, significant changes in ovarian function lead to a characteristic decline in progesterone levels. This process is driven by two primary mechanisms: the complete absence of ovulation and the reduced functional capacity of the corpus luteum when ovulation does occur.

Clinical evidence

Research involving women in the perimenopausal transition (STRAW+10 stages) demonstrates a progressive increase in anovulatory cycles. In late perimenopause, the frequency of cycles without ovulation can exceed 60%. These cycles are characterized by profound progesterone deficiency because the corpus luteum, which is responsible for nearly all progesterone production during the luteal phase, never forms.

• Progesterone levels: Clinical studies show that mean progesterone in anovulatory cycles is approximately 3.8 nmol/L, compared to roughly 24.5 nmol/L in healthy ovulatory cycles.
• Luteal Phase Deficiency (LPD): Even when ovulation occurs, perimenopausal cycles often exhibit a shortened or insufficient luteal phase. Research indicates that "normal" mid-luteal progesterone levels (typically >4.5 ng/mL) are frequently not reached in this population due to impaired follicle development and subsequent luteal dysfunction.

Mechanistic explanations

The decline in progesterone is rooted in the cellular aging of the ovary and dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis.

• Steroidogenic pathways: Following ovulation, granulosa and theca cells undergo luteinization to become luteal cells. This process requires the transport of cholesterol into the mitochondria via the steroidogenic acute regulatory protein (StAR) and conversion into progesterone through enzymes such as 3β-hydroxysteroid dehydrogenase (3β-HSD).
• Granulosa cell aging: In perimenopause, granulosa cells experience mitochondrial dysfunction, oxidative stress, and increased apoptosis. These cellular impairments compromise their ability to differentiate into functional luteal cells, resulting in defective steroidogenesis.
• HPG axis dysregulation: Fluctuating levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) lead to suboptimal luteinization and an inadequate "signal" for the corpus luteum to produce sufficient progesterone.

Bottom line

The claim is strongly supported by scientific evidence. Perimenopause increases the frequency of anovulatory cycles and reduces the quality of the corpus luteum, both of which lead to significantly lower progesterone levels and clinical luteal insufficiency.